HIMS Hims & Hers Health, Inc.

bullish track record → $26.99 +2.70 (+11.1%)
Mkt Cap $5B P/E 38.5 fwd 14.9 52wk $13.74 - $70.43 Earnings beating Earnings 2026-05-04 1h ago
Insider selling: $2,955,860 sold by 8 insiders (30d)
Est. revisions: +222.6%
Backed by structured data (insider trades, analyst ratings, or filings)
Factor Model (net +1.5)

Factor Model

net +1.5 2.8 / 10
Est. Revisions
+1.0
Insider Activity
+0.0
Momentum
-0.2
Analyst Rev.
+0.0
Narrative Gap
+0.0

Hims shares surge 25% on peptide policy buzz

Watch: FDA peptide policy outcome in July 2026 for regulatory clarity and commercial implications on HIMS's telehealth peptide business.

HIMS stock jumped 25% following a report that RFK Jr.'s upcoming peptide policy meeting could boost telehealth growth avenues, shifting investor focus to peptides despite limited clinical efficacy data. The FDA's Pharmacy Compounding Advisory Committee meeting on peptides is scheduled for July 2026. This comes after a neutral analyst rating from B of A Securities and strong institutional support, though insiders continue selling.

The peptide policy could open new revenue streams in telehealth for HIMS, supporting its recent stock momentum and analyst bullishness despite margin pressures and insider selling.

Evidence

2h ago CNBC - RFK Jr.'s peptide policy could boost Hims & Hers as its GLP-1 business evolves reddit-stocks
18h ago B of A Securities main HIMS: Neutral → Neutral
16d ago US FDA is expected to lift restriction on certain peptides, NYT reports reddit-stocks
19d ago Hims & Hers shifts business model after Novo deal yahoo-finance
25d ago Hims & Hers (HIMS) Tumbles 8.86% on Market Bloodbath, Profit-Taking yahoo-finance
28d ago Insider other by AUTOR DEBORAH M (HIMS): undisclosed value
28d ago Insider other by BECKLUND IRENE (HIMS): undisclosed value
28d ago Insider other by PENDARVIS CHRISTIANE (HIMS): undisclosed value
7 older signals
28d ago Insider other by OKUPE OLUYEMI (HIMS): undisclosed value
28d ago Insider other by CHI MICHAEL Y (HIMS): undisclosed value
28d ago Insider other by CARROLL PATRICK HARRISON (HIMS): undisclosed value
31d ago Leerink Partners main HIMS: Market Perform → Market Perform
31d ago Hims & Hers (HIMS) Soars 57.4% on New Deal
34d ago Barclays Raises PT on Hims & Hers Health (HIMS) Stock
35d ago Barclays Raises Hims & Hers (HIMS) Target to $29 After Novo Deal Clears Legal Overhang — Canaccord Cuts Progyny (PGNY) on Cautious 2026 Outlook
Fundamentals & Data ▾
Hims & Hers Health, Inc. Healthcare · Drug Manufacturers - Specialty & Generic
Mkt Cap
$5B
P/E
38.5 fwd 14.9
Beta
2.31
52w Range
$13.74 - $70.43
Short Interest
71.4M 38.71%
Days to Cover
2.0 -16%
Technicals uptrend
vs 20d MA
+15.0%
vs 50d MA
+21.9%
from 52w Hi
-63.3%
Vol (20d)
92%
1w return
+25.3%
1m return
-1.9%
3m return
-24.9%
Vol ratio
0.9x
Insiders
selling 0B / 10S
Analysts
bullish 2 up / 0 down
Earnings
beating 3B / 1M
EPS Estimate
$0.04 +222.6% 30d 0up / 0dn
Est. Dispersion
470% 10 analysts
Analyst Target
$24 $16 - $30
Options P/C
0.21 4C / 5P unusual
Insider Cluster
strong sell 0B / 4S
Fund Convergence
strong Citadel, Renaissance, D.E. Shaw, Bridgewater
Financials
Revenue
$618M +28% YoY
FCF
$-3M
Gross Margin
72%
Op Margin
2%
Momentum: decelerating
Top Holders
Citadel $425M
Renaissance $156M
D.E. Shaw $37M
Bridgewater
Recent Filings & Data
insider trade 14
net selling · $2,955,860 sold
8 insiders · 14 transactions (30d)
Recent transactions
BOUGHTON SOLEIL · sell · $118,808
CHI MICHAEL Y · sell · $2,402,065
BECKLUND IRENE · sell · $136,511
CARROLL PATRICK HARRISON · other
CHI MICHAEL Y · other
OKUPE OLUYEMI · other
PENDARVIS CHRISTIANE · other
BECKLUND IRENE · other
AUTOR DEBORAH M · other
DUDUM ANDREW · other
OKUPE OLUYEMI · sell · $79,409
OKUPE OLUYEMI · exercise · $19,915
OKUPE OLUYEMI · sell · $219,067
OKUPE OLUYEMI · exercise · $22,490
Track Record (1/1 correct) ▾

Direction History

1/1 correct at 5 days
2026-03-07 bullish +57.4% ✓
Full track record across all stocks →
15 signals · latest 2h ago

Get alerted when HIMS changes direction

We'll email you when our AI detects a shift — reversals, insider clusters, filing red flags.

All stocks → Our calls → How it works →